1-7 of 7
Sophie Auger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Yttrium-90 Ibritumomab Tiuxetan Is Feasible and Efficient in Unselected Patients. Definitive Results of a Large Retrospective Phase IV Study

Valentine Richez, Jr., MD, Julie Abraham, MD, Sandy Amorim, MD, Charles Herbaux, MD, Laure Philippe, MDcal student, Marc Andre, MD, Anne Parcelier, MD, Christophe Fruchart, MD, Krimo Bouabdallah, MD, Jérôme Cornillon, MD, Sigrid Cherrier, MD, Clementine Salvado, MD, Bernard Drenou, MD, Lucie Oberic, MD, Philippe Quittet, MD, Geoffroy Venton, MD, Claire Calmettes, MD, Safia Chebrek, MD, Cedric Rossi, MD, Arnaud Campidelli, MD, Bruno Lioure, MD, Sophie Auger, MD, Lucille Altounian, MD, Philippe Mineur, MD, Erwin Woff, MD, Frederic Peyrade, MD
Journal: Blood
Blood (2015) 126 (23): 5108.
https://doi.org/10.1182/blood.V126.23.5108.5108
Published: 2015
Journal Articles

Controlled Epstein-Barr Virus Reactivation After Allogenic Transplantation Improves Survival and Is Associated To An Expansion Of Natural Killer Cells (NK)

Sophie Auger, MD, Mattea Orsini, Patrice Ceballos, MD, Nathalie Fegueux, MD, Bernard Klein, PhD, Martin Villalba, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4594.
https://doi.org/10.1182/blood.V122.21.4594.4594
Published: 2013
Journal Articles

ETV6-ABL1 CML Like Disorder with Complex Translocation Involving Chromosome 9, 12 and 14

Sophie Auger, MD, Jean Baptiste Gaillard, MD, Thierry Lavabre-Bertrand, PhD, Sandrine Hayette, Philippe Quittet, MD, Daniel Donadio, MD, Carole Exbrayat, MD
Journal: Blood
Blood (2012) 120 (21): 4438.
https://doi.org/10.1182/blood.V120.21.4438.4438
Published: 2012
Journal Articles

Use of Rituximab As a Pre-Emptive Therapy for Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorders in 86 Adult Patients Having Allogeneic Stem Cell Transplantation

Sophie Auger, MD, Mattea Orsini, Nathalie Fegueux, Patrice Ceballos, MD, Marie Luce Mines, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1995.
https://doi.org/10.1182/blood.V118.21.1995.1995
Published: 2011
Journal Articles

Bortezomib Overcomes Usual Prognosis Factor in Patients with Multiple Myeloma (MM) Having High Dose Therapy (HDT)

Sophie Auger, MD, Philippe Quittet, MD, Salaheddine Bouhya, MD, Tarik Kanouni, MD, Pascal Latry, MD, Mattea Orsini, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3104.
https://doi.org/10.1182/blood.V118.21.3104.3104
Published: 2011
Journal Articles

Febrile Neutropenia, Mucositis and Duration of Hospitalization Are Reduced After Pegfilgrastim Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) for Malignant Lymphopathies: Report of 683 PBSCTs From a Single Institution.

Sophie Auger, Philippe Quittet, MD, Marie Cecile Bozonnat, MD, Salahedine Bouya, MD, Tarik Kanouni, MD, Nathalie Fegueux, MD, Patrice Ceballos, MD, Jean-Côme Meniane, MD, Guillaume Cartron, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3410.
https://doi.org/10.1182/blood.V114.22.3410.3410
Published: 2009
Journal Articles

Multiple Myeloma Is Exceptional in Paediatrics: Report of One Case From 1200 Patients in a Single Institution.

Sophie Auger, Genevieve Margueritte, MD, Renaud Tichit, MD, Basheer Khalil, Philippe Quittet, MD, Nathalie Fegueux, MD, Patrice Ceballos, MD, Jean-Francois Rossi, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4957.
https://doi.org/10.1182/blood.V114.22.4957.4957
Published: 2009